Molecular And Cellular Basis For The Analgesic Properties Of N-Arachidonyl Amino Acids
Funder
National Health and Medical Research Council
Funding Amount
$509,017.00
Summary
Chronic pain affects 20% of the population of Australia, but current treatments for chronic pain are often problematic. A recently described class of compounds, the arachidonyl amino acids, show particular promise as analgesic agents, but at present there is very little understanding of how these compounds mediate their analgesic effects. In this project we will apply a variety of molecular, cellular and behavioural approaches to understand how the arachidonyl amino acids provide pain relief.
Intercellular RNA Transport In Mammals: Function And Significance
Funder
National Health and Medical Research Council
Funding Amount
$384,213.00
Summary
It was recently discovered that the nucleic acid RNA can turn genes off very potently. This raises the exciting possibility of using RNA as a new treatment for a wide range of diseases including cancer and infection. However, it is not known how RNA enters cells in our body. This project aims to understand how RNA is transported across cell membranes, will explore the significance of this process, and should ultimately assist efforts to develop more effective RNA-based therapeutics.
The Role Of 'Orphan' Transporters In Bone Homeostasis And Disease
Funder
National Health and Medical Research Council
Funding Amount
$675,668.00
Summary
Osteoclasts (OCs) are giant multinucleated cells exclusively responsible for physiological bone degradation (resorption). Excessive OC activity leads to localised bone destruction (osteolysis) as observed in patients with osteoarthritis and underlies decreased bone mass and fragility fractures that are a hallmark of osteoporosis. This project examines the role of an orphan solute carrier transporter in OC function and its potential involvement in bone disease.
Epilepsy is often poorly controlled by medication and dietary measures can be taken that reduce occurrence of epileptic seizures. Glucose control is impacted by diet and also mutations in the genes that move glucose around the body are known to cause epilepsy. Here we will be studying how the genetic and dietary control of glucose levels impacts brain function to increase seizures and to potentially reveal novel therapies.
Protecting The Efficacy Of Antimalarial Therapies With Novel Approaches To Suppress The Emergence Of Drug Resistance
Funder
National Health and Medical Research Council
Funding Amount
$408,768.00
Summary
The global campaign to eliminate malaria is under serious threat from the continuing emergence and spread of Plasmodium falciparum parasites resistant to antimalarial drugs. However in acquiring resistance to one drug, the parasite can become more susceptible to other antimalarials. This project aims to 1) test the ability of drug pairs with opposing selection forces to suppress resistance in vitro and 2) define the physiological and molecular basis of these opposing evolutionary forces.